Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-08-07 | AcouSort | AcouSort invited to give a lecture at the Acoustofluidics conference | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-07 | AcouSort | AcouSort inbjudet att föreläsa på Acoustofluidics-konferens | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-05 | AcouSort | AcouSort: Cell therapy collaboration with leading global life science company continues to expand | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-05 | AcouSort | AcouSort: Cellterapisamarbetet med ett ledande globalt life science-företag fortsätter att expandera | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-16 | AcouSort | AcouSort stärker sin FoU-kapacitet genom rekrytering av Henrik Johansson | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-16 | AcouSort | AcouSort strengthens its R&D capabilities by the recruitment of Henrik Johansson | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-14 | Analyst Group | Analyst Group: Aktieanalys på AcouSort - Hög aktivitetsnivå och kommersiella framgångar möjliggör tillväxt | Pressreleaser | Visa Stäng |
|
||||
2023-06-07 | AcouSort | AcouSort continues its strategic collaboration with academia- delivers a unique AcouWash 2 system to Lund University | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-07 | AcouSort | AcouSort fortsätter sitt strategiska samarbete med akademin -levererar unikt AcouWash 2-system till Lunds universitet | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-31 | Analyst Group | Analyst Group: Analyst Group kommenterar AcouSorts Q1-rapport | Pressreleaser | Visa Stäng |
|
||||
2023-05-31 | AcouSort | AcouSort AB - Interim Report for the period January - March 2023 | Rapporter | Ladda ner | Visa Stäng |
Rapporter |
AcouSort AB – Interim Report for the period January – March 2023Significant events during the first quarter On January 19, AcouSort announces that the Company has delivered a prototype system for stem cell separations to its Blue4Therapy project partner BlueCell Therapeutics. The companies have now proceeded to the commercial planning phase. On January 20, AcouSort announces that the first part of the cell therapy project announced in November is now successfully finalized. The two companies have jointly decided to extend the collaboration with a second phase generating revenues of EUR 130,000 to AcouSort in 2023. On February 8, AcouSort announces that the collaboration agreement together with an international Japanese life science company has been extended to allow final evaluation of the developed assay using clinical samples. On March 3, AcouSort announces that the Company has updated its strategy to meet a rising demand for automated cell processing solutions from the cell therapy market. Significant events after the end of the period On April 3, AcouSort announces that the stem cell therapy project Blue4Therapy has been brought to a highly successful close. On April 14, AcouSort announces that the Company has leased an AcouWash system to a Czech research group investigating fish sperm refinement. On April 21, AcouSort announces that the Company for the third time has been selected by the EIC for participation in a leading medical exhibition. On April 26, AcouSort announces that the prestigious US National Institute of Health (NIH) has ordered an AcouWash 2 system, thereby becoming a returning customer. In 2017, the NIH purchased the first AcouWash prototype for the cell wash process in a new monitoring method for cancer treatments. On May 15, AcouSort announces that the Company expands its reach through a new collaboration with a leading Life Science company developing flow cytometers. On May 22, AcouSort announces the launch of the next generation AcouTrap at CYTO 2023. The new AcouTrap 3 system comes with improved design and an updated and intuitive software graphical user interface. AcouSort also presents two new trapping units with improved performance. CEO COMMENTS Positive start to the year with high activity level and AcouSort Group has had a very positive start of 2023. Our increasing marketing efforts continued to deliver strong results with total income in the first quarter amounting to SEK 3.848 (2.687) million, corresponding to growth of 43%. Our activity level has remained high in the commercial side as well as in our innovation efforts. Commercial successes Perhaps the most noteworthy commercial success so far this year was made in January when we received an order with a total value of EUR 130,000 from a global Life Science company active within cell therapy. The deal represents an extension of a project that was initiated in November 2022. Cell therapy is an area where we see a great potential for our technology within sample preparation automation. Our ambition is to form long-term relationships with our customers to establish a solid stream of recurring revenues through sales of OEM components. We are not there yet, but with an increasing number returning customers in our commercial research and development projects we are moving toward this ultimate objective. Another very significant deal was the AcouWash order placed by the prestigious US National Institutes of Health (NIH) becoming a returning customer to AcouSort. In 2017, NIH purchased the first AcouWash prototype for the cell wash process in a new monitoring method for cancer treatments that NIH were developing. In April 2023, we received an order from NIH for the new AcouWash 2 system with a total value of USD 50,000 or SEK 516,000. Having NIH as a returning customer is something which makes us really proud as it puts a true seal of excellence on our technology and our operations. It is not always clear which activities or collaborations that will lead to high value business opportunities. One example of this is the leasing of an AcouWash system to a research group in the Czech Republic. During the fall of 2021, AcouSort was visited for one month by a PhD student from the Czech research group working within fish reproduction. The purpose was to investigate if the AcouWash technology could be used to separate fish sperm with high motility to improve the insemination results in animal breeding and for future medicinal use. This interesting field of collaboration now continues with the lease of the AcouWash system. Highly successful close of the Blue4Therapy project In the beginning of April, the stem cell therapy project Blue4Therapy was brought to a highly successful close. The Blue4Therapy project was initiated in May 2020 with the ambition to develop clinical applications in cell therapy and stem cell treatments – two areas with great commercial potential for AcouSort. Project partners were the University of Southern Denmark, BlueCell Therapeutics, Novozymes and AcouSort. AcouSort’s contribution to the project has been to develop a module for the purification of stem cells in a point-of-care environment (POC). The project has now been successfully finalized and the applications and hardware that AcouSort has developed within the Blue4Therapy framework have significantly strengthened our position within cell therapy. EIC continues to display trust in AcouSort The European Innovation Council (EIC) continues to display trust in AcouSort. We have now for the third time been selected by the EIC for participation in a leading medical exhibition, this time in the European Pavilion at BIO 2023 in Boston, USA, after a highly competitive evaluation process. AcouSort is thereby one of 17 European companies selected by the EU for full sponsorship at America’s leading medical exhibition, taking place in Boston June 5-8. Continued interest in our unique technology AcouSort’s technology can be used in a number of medical applications, one of which is flow cytometry, a technology that rapidly analyzes single cells or particles. During the last year, we have been approached by several flow cytometry companies, and we have now entered into a collaboration with one of the main players in this field. The purpose is to evaluate the potential of our AcouWash technology to improve sample preparation and sample clean-up before flow cytometry analysis. The initial phase of this collaboration consists of a lease of one AcouWash system and an application support package. This collaboration is especially interesting as it opens up yet another potential area for our AcouWash technology. Torsten Freltoft – CEO The report is attached below and can also be found at https://acousort.com/investor/financial-reports/ |
||||
2023-05-31 | AcouSort | AcouSort AB - delårsrapport för perioden januari - mars 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-26 | AcouSort | AcouSort launches next generation AcouTrap at CYTO 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-26 | AcouSort | AcouSort lanserar nästa generations AcouTrap på CYTO 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-15 | AcouSort | AcouSort expanderar till flödescytometri | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-15 | AcouSort | AcouSort expands its reach to flow cytometry | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-26 | AcouSort | The prestigious US National Institute of Health becomes a returning customer to AcouSort | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-26 | AcouSort | Det prestigefyllda amerikanska National Institute of Health blir en återkommande kund till AcouSort | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-25 | AcouSort | Kommuniké från årsstämma i AcouSort AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-21 | AcouSort | AcouSort selected by EIC for participation in leading medical exhibition for the third time | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-21 | AcouSort | AcouSort utvalt av EIC för deltagande i ledande medicinsk konferens för tredje gången | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-14 | AcouSort | AcouSort: Tjeckisk forskargrupp ser helt nya möjligheter för AcouWash vid förfining av fiskspermier | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-14 | AcouSort | AcouSort: Czech research group sees novel opportunities for AcouWash in fish sperm refinement | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-11 | AcouSort | Komplettering av kallelse till årsstämma i AcouSort AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-03 | AcouSort | AcouSort: The stem cell therapy project Blue4Therapy brought to a highly successful close | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-03 | AcouSort | AcouSort: Stamcellsterapiprojektet Blue4Therapy har slutförts på ett mycket framgångsrikt sätt | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-28 | AcouSort | AcouSort Årsredovisning 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-03-28 | AcouSort | Kallelse till årsstämma i AcouSort AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-06 | Analyst Group | Analyst Group: Aktieanalys på AcouSort - Står inför ett genombrottsår | Pressreleaser | Visa Stäng |
|
||||
2023-03-03 | AcouSort | AcouSort: Strategiuppdatering | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-03 | AcouSort | AcouSort: Strategy update | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-22 | Analyst Group | Analyst Group: Analyst Group kommenterar AcouSorts Q4-rapport | Pressreleaser | Visa Stäng |
|
||||
2023-02-22 | AcouSort | AcouSort AB - Bokslutskommuniké för räkenskapsåret 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | AcouSort | AcouSort: Japanese collaboration agreement extended to allow final evaluation of performance on clinical samples | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | AcouSort | AcouSort: Japanskt samarbetsavtal förlängs för att möjliggöra slutlig utvärdering med kliniska prover | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-20 | Analyst Group | Analyst Group: Analyst Group kommenterar AcouSorts utökade cellterapisamarbete | Analyser | Visa Stäng |
|
||||
2023-01-20 | AcouSort | AcouSort: Extended collaboration targeting cell therapies generates revenues of EUR 130,000 in 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-20 | AcouSort | AcouSort: Utökat cellterapisamarbete genererar intäkter på 130 000 euro under 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-19 | AcouSort | AcouSort och BlueCell i kommersiell planering i takt med att stamcellsterapiprojektet Blue4Therapy närmar sig slutförande | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-19 | AcouSort | AcouSort and BlueCell in commercial planning as the stem cell therapy project Blue4Therapy approaches completion | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-12-06 | Analyst Group | Analyst Group: Aktieanalys på AcouSort - Momentum i samtliga affärsområden | Analyser | Visa Stäng |
|
||||
2022-12-05 | AcouSort | Two of AcouSort's board members and CEO acquire shares | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-12-05 | AcouSort | Två av AcouSorts styrelsemedlemmar och vd förvärvar aktier | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-12-01 | AcouSort | AcouSort: The BioWings project creates new opportunities for large-scale production and exosome-based diagnostics | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-12-01 | AcouSort | AcouSort: BioWings-projektet skapar nya möjligheter för storskalig produktion och exosombaserad diagnostik | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-24 | AcouSort | AcouSort presenterar på Stora Aktiedagen i Stockholm den 30 november för att tala om utvecklingen inom det intensiva cellterapiområdet | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-24 | AcouSort | AcouSort presents at Stora Aktiedagen in Stockholm, November 30, addressing current developments in the vibrant cell therapy space | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-23 | Analyst Group | Analyst Group: Analyst Group kommenterar AcouSorts Q3-rapport | Analyser | Visa Stäng |
|
||||
2022-11-23 | AcouSort | AcouSort AB - delårsrapport för perioden januari - september 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-11-15 | Analyst Group | Analyst Group: Analyst Group kommenterar att AcouSort expanderar inom cellterapi och etablerar samarbete med globalt life science-bolag | Analyser | Visa Stäng |
|
||||
2022-11-14 | AcouSort | AcouSort expands its cell therapy efforts and enters collaboration with global life science company | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-14 | AcouSort | AcouSort expanderar sin verksamhet inom cellterapi och etablerar samarbete med globalt life science-bolag | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-11 | AcouSort | AcouSort to supply Lund University with unique pre-focusing technology to enable high precision cell separation | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-11 | AcouSort | AcouSort förser Lunds universitet med unik förfokuseringsteknik för att möjliggöra cellseparation med hög precision | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-10-21 | AcouSort | AcouSort reser till Japan för att återuppta marknadsföringsarbetet när landet nu öppnar upp efter pandemin | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-10-21 | AcouSort | AcouSort travels to Japan to re-ignite marketing efforts as the country opens up after the pandemic | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-10-14 | AcouSort | AcouSort's role in the Blue4Therapy project expands - SEK 700,000 in additional revenue in 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-10-14 | AcouSort | AcouSorts roll i Blue4Therapy-projektet expanderar - 700 000 SEK i ytterligare intäkter under 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-22 | AcouSort | AcouSort: Kom till Aktiedagen Lund 26 september för att få veta mer om hur ultraljud kan användas för att bekämpa världens dödligaste sjukdomar | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-22 | AcouSort | AcouSort: Visit Aktiedagen Lund September 26, and learn how ultrasound can be used to fight the world's deadliest diseases | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-09 | AcouSort | AcouSort utvalt av EIC för deltagande på MEDICA, Europas ledande medicinska utställning | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-09 | AcouSort | AcouSort selected by EIC for participation at MEDICA, Europe's leading medical exhibition | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-02 | Analyst Group | Analyst Group: Aktieanalys på AcouSort - Validering av teknikhöjd efter viktigt forskningsanslag | Analyser | Visa Stäng |
|
||||
2022-08-25 | Analyst Group | Analyst Group: Analyst Group kommenterar AcouSorts Q2-rapport | Analyser | Visa Stäng |
|
||||
2022-08-24 | AcouSort | AcouSort AB - delårsrapport för perioden januari - juni 2022 | Rapporter | Ladda ner | Visa Stäng |
|